Share your insights

Help us by sharing what content you've recieved in your exams


Psoriasis

Background knowledge ๐Ÿง 

Definition

  • Psoriasis is a chronic inflammatory skin condition characterized by erythematous plaques with silvery scales.
  • It is an autoimmune disorder involving hyperproliferation of keratinocytes.
  • Primarily affects the skin, but can also involve the nails and joints.

Epidemiology

  • Affects 2-3% of the UK population.
  • Equal prevalence in men and women.
  • Most commonly presents between ages 15-35.
  • Genetic predisposition with polygenic inheritance pattern.

Aetiology and Pathophysiology

  • Exact cause unknown; involves genetic, immunological, and environmental factors.
  • T-cell mediated immune response causing keratinocyte hyperproliferation.
  • Triggers include infections, stress, skin trauma, and medications.
  • Increased levels of inflammatory cytokines like TNF-alpha and IL-17.

Types

  • Plaque psoriasis: Most common type, characterized by well-demarcated plaques.
  • Guttate psoriasis: Small, drop-shaped lesions, often triggered by streptococcal infection.
  • Pustular psoriasis: Characterized by pustules, can be localized or generalized.
  • Erythrodermic psoriasis: Severe form involving widespread erythema and scaling.
  • Inverse psoriasis: Affects skin folds with smooth, red lesions.
  • Nail psoriasis: Involves pitting, onycholysis, and subungual hyperkeratosis.

Clinical Features ๐ŸŒก๏ธ

Symptoms

  • Itching and discomfort in affected areas.
  • Pain, particularly in cases with joint involvement (psoriatic arthritis).
  • Psychological impact, including anxiety and depression.
  • Fatigue, especially in more severe cases.

Signs

  • Erythematous plaques with silvery scales, commonly on extensor surfaces.
  • Auspitz sign: Removal of scale leads to pinpoint bleeding.
  • Koebner phenomenon: Lesions appearing at sites of trauma.
  • Nail changes: Pitting, onycholysis, and subungual hyperkeratosis.
  • Arthritis: Swelling and tenderness of joints in psoriatic arthritis.

Investigations ๐Ÿงช

Tests

  • Clinical diagnosis primarily based on history and examination.
  • Skin biopsy: May be used to confirm diagnosis in atypical cases.
  • Blood tests: ESR, CRP may be elevated, especially in psoriatic arthritis.
  • Imaging: X-rays or MRI in cases of suspected psoriatic arthritis.
  • PASI (Psoriasis Area and Severity Index) to assess severity.

Management ๐Ÿฅผ

Management

  • Topical treatments: Emollients, corticosteroids, vitamin D analogues.
  • Phototherapy: Narrowband UVB is most commonly used.
  • Systemic treatments: Methotrexate, ciclosporin, biologics (e.g., TNF inhibitors).
  • Lifestyle modifications: Smoking cessation, weight management.
  • Multidisciplinary approach: Dermatologists, rheumatologists, and psychologists.
  • Patient education: Importance of adherence to treatment and understanding of triggers.

Complications

  • Psoriatic arthritis: Occurs in up to 30% of patients.
  • Cardiovascular disease: Increased risk due to systemic inflammation.
  • Metabolic syndrome: Higher prevalence in patients with psoriasis.
  • Psychosocial impact: Depression, anxiety, and social stigma.
  • Infection risk: Due to immunosuppressive treatments.

Prognosis

  • Chronic condition with relapsing-remitting course.
  • Severity varies widely; some patients have mild, localized disease, others severe, widespread involvement.
  • Early treatment and adherence can improve outcomes.
  • Complications like psoriatic arthritis may impact long-term prognosis.

Key Points

  • Psoriasis is a common, chronic inflammatory skin condition with systemic implications.
  • Multifactorial aetiology involving genetic and environmental factors.
  • Management requires a combination of topical, systemic, and lifestyle interventions.
  • Early recognition and treatment of complications, especially psoriatic arthritis, are crucial.

No comments yet ๐Ÿ˜‰

Leave a Reply